GSK2018682 FTIH in Healthy Volunteers

NCT01387217 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: GSK2018682
DRUG: Placebo

Sponsor

GlaxoSmithKline